CORC

在结果中检索

CORC

浏览/检索结果: 共46条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
MUC3A Induces PD-L1 and Reduces Tyrosine Kinase Inhibitor Effects in EGFR-Mutant Non-Small Cell Lung Cancer 会议论文
作者:  Luo, Y.;  Xie, C.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
EGFR  MUC3A  PD-L1  
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer 会议论文
CANCER RESEARCH, 2019-02-01
作者:  Zhu, A.;  Yuan, P.;  Wang, J.;  Fan, Y.;  Luo, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文
作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Differential therapeutic responses of MET oncogenic activations to Met kinase inhibitor and neutralizing antibody 会议论文
作者:  Kou, Jianqun;  Staal, Ben;  Musich, Phillip R.;  Kang, Liang;  Qin, Yuan
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial 会议论文
BLOOD, 2018-11-29
作者:  Song, Yuqin;  Zhou, Keshu;  Zou, Dehui;  Zhou, Jianfeng;  Hu, Jianda
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib 会议论文
作者:  Liu, Fatao;  Zhou, Yi;  Zhou, Zhen;  Liu, Yun;  Chen, Zhiwei
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor 会议论文
作者:  Chen, Xinru;  Zhang, Yu;  Lu, Jiabin;  Xu, Chunwei;  Liang, Jianzhong
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
A phase II multicenter trial of the multitargeted kinase inhibitor sulfatinib in advanced medullary thyroid cancer (MTC) and radioiodine (RAI)-refractory differentiated thyroid cancer (DTC). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Chen, Jiaying;  Ji, Qinghai;  Cao, Junning;  Ji, Dongmei;  Bai, Chunmei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
Phase I study of single-agent pyrotinib, a novel irreversible pan-ErbB receptor tyrosine kinase inhibitor, in patients with ErbB2+metastatic breast cancer 会议论文
作者:  Xu, B.;  Ma, F.;  Chen, S.;  Li, Q.;  Yang, F.
收藏  |  浏览/下载：12/0  |  提交时间：2019/01/08
Phase I study of single-agent pyrotinib, a novel irreversible pan-ErbB receptor tyrosine kinase inhibitor, in patients with ErbB2+metastatic breast cancer 会议论文
CANCER RESEARCH, 2016-02-15
作者:  Xu, B.;  Ma, F.;  Chen, S.;  Li, Q.;  Yang, F.
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace